about
Endoplasmic reticulum stress and diabetic cardiomyopathyInvolvement of endoplasmic reticulum stress in myocardial apoptosis of streptozocin-induced diabetic ratsImprovement of cardiac functions by chronic metformin treatment is associated with enhanced cardiac autophagy in diabetic OVE26 miceAutophagic adaptations in diabetic cardiomyopathy differ between type 1 and type 2 diabetes.Diabetic cardiomyopathy and reactive oxygen species (ROS) related parameters in male and female rats: A comparative study.Therapy insight: Influence of type 2 diabetes on the development, treatment and outcomes of cancer.Systolic aortic pressure-time area is a useful index describing arterial wave properties in rats with diabetes.Insulin infusion therapy for myocardial infarction.Vascular endothelial growth factor inhibition by dRK6 causes endothelial apoptosis, fibrosis, and inflammation in the heart via the Akt/eNOS axis in db/db mice.Present Insights on Cardiomyopathy in Diabetic Patients.Nuclear factor (erythroid-derived 2)-like 2 (NFE2L2) is a novel therapeutic target for diabetic complications.Double-stranded RNA-dependent protein kinase signalling and paradigms of cardiometabolic syndrome.Mitochondrial miRNAs in diabetes: just the tip of the iceberg.Targeting Metabolic Modulation and Mitochondrial Dysfunction in the Treatment of Heart Failure.Role of tissue transglutaminase in the pathogenesis of diabetic cardiomyopathy and the intervention effect of rutin.Mechanical circulatory support improves diabetic control in patients with advanced heart failure.Insulin status differentially affects energy transduction in cardiac mitochondria from male and female rats.Restoring calcium homeostasis in diabetic cardiomyocytes: an investigation through mathematical modelling.Melatonin protects against diabetic cardiomyopathy through Mst1/Sirt3 signaling.Inhibition of HDAC3 prevents diabetic cardiomyopathy in OVE26 mice via epigenetic regulation of DUSP5-ERK1/2 pathway.MST1 coordinately regulates autophagy and apoptosis in diabetic cardiomyopathy in mice.miR-30c and miR-181a synergistically modulate p53-p21 pathway in diabetes induced cardiac hypertrophy.Early myocardial impairment in type 1 diabetes patients without known heart disease assessed with tissue Doppler echocardiography: The Thousand & 1 study.Activating Cannabinoid Receptor 2 Protects Against Diabetic Cardiomyopathy Through Autophagy Induction
P2860
Q27016164-F5E3D9A4-C251-426D-9C94-9BCEB9952E8FQ30496528-03022F74-9920-4258-9353-D8E8AA3EE9C1Q35043474-1C552A28-0DDD-42F5-A8B1-AF68B46712AEQ36111734-99735726-4506-4F5D-A19B-8DE1F8496EFBQ36266076-0EEB025B-F5C6-44B3-B69E-BEA93EC442E0Q36303910-B4C5EFE8-FFA6-466F-B9CC-FD3C752CB5EDQ36333399-C29D68D8-ABD8-4B1D-AD3A-034DCC8CC002Q36675392-D577E6A6-B0E1-473D-9A85-AE0E51ADA795Q37400759-049F8993-F505-46DC-9946-813B324971BAQ37402793-F92A01B8-2E3A-440F-88DA-150810104772Q38097416-6385850A-19F7-4B64-966E-EA44C6BF21B7Q39043385-1F2752DE-5A84-4FD1-B1C7-DFCB133004D2Q39280722-D122BFCD-9130-4922-89F5-520148355A83Q41297700-EDCD8653-DD14-4604-BC56-26F2A1C46431Q43180714-B530013B-7E34-494B-9091-48D45FA7BBF7Q45232893-4EDBC9FF-EE6F-4F09-8061-F48249447C75Q46860937-C1842108-3F7D-4354-AC6E-7DB7A3F3CAEAQ47731523-CDE98636-8A7A-4082-BD60-8AC39E45530FQ48180152-F4EF129C-1C44-4CB4-98D0-8C2EE343AA45Q50630504-0239953D-8367-485E-8FAB-937444BF58E7Q51579272-1EF8A217-9DC1-4A21-849B-75A258F20B56Q53095027-E9004A74-E073-4D0A-A558-20A5A0BE53CAQ53097634-92E644F6-CF3C-4609-8E46-13D4FD44F493Q59136439-A7687531-5012-4966-9449-A20646DDF32B
P2860
description
2004 nî lūn-bûn
@nan
2004 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Diabetic cardiomyopathy: a metabolic perspective.
@ast
Diabetic cardiomyopathy: a metabolic perspective.
@en
Diabetic cardiomyopathy: a metabolic perspective.
@nl
type
label
Diabetic cardiomyopathy: a metabolic perspective.
@ast
Diabetic cardiomyopathy: a metabolic perspective.
@en
Diabetic cardiomyopathy: a metabolic perspective.
@nl
prefLabel
Diabetic cardiomyopathy: a metabolic perspective.
@ast
Diabetic cardiomyopathy: a metabolic perspective.
@en
Diabetic cardiomyopathy: a metabolic perspective.
@nl
P2093
P1476
Diabetic cardiomyopathy: a metabolic perspective.
@en
P2093
Angelo Avogaro
Antonio Tiengo
Christian Negut
Roldano Scognamiglio
Saula Vigili de Kreutzenberg
P304
P356
10.1016/J.AMJCARD.2003.11.003
P407
P577
2004-04-01T00:00:00Z